ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 09:15 am Sale | 2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | ADAGE CAPITAL PARTNERS GP L.L.C. | 650,000 1.390% | -1,850,000 (-74.00%) | Filing |
| 2021-02-11 07:39 am Purchase | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,500,000 6.320% | 600,000 (+31.58%) | Filing |
| 2020-07-24 4:05 pm Purchase | 2020-07-14 | 13G | Celldex Therapeutics, Inc. CLDX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,900,000 5.010% | 1,900,000 (New Position) | Filing |